<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:p="urn:schemas-microsoft-com:office:powerpoint" xmlns:a="urn:schemas-microsoft-com:office:access" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s="uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs="urn:schemas-microsoft-com:rowset" xmlns:z="#RowsetSchema" xmlns:b="urn:schemas-microsoft-com:office:publisher" xmlns:ss="urn:schemas-microsoft-com:office:spreadsheet" xmlns:c="urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc="urn:schemas-microsoft-com:office:odc" xmlns:oa="urn:schemas-microsoft-com:office:activation" xmlns:html="http://www.w3.org/TR/REC-html40" xmlns:q="http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc="http://microsoft.com/officenet/conferencing" xmlns:D="DAV:" xmlns:Repl="http://schemas.microsoft.com/repl/" xmlns:mt="http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2="http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda="http://www.passport.com/NameSpace.xsd" xmlns:ois="http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir="http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds="http://www.w3.org/2000/09/xmldsig#" xmlns:dsp="http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc="http://schemas.microsoft.com/data/udc" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:sub="http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec="http://www.w3.org/2001/04/xmlenc#" xmlns:sp="http://schemas.microsoft.com/sharepoint/" xmlns:sps="http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs="http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf="http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p="http://schemas.microsoft.com/data/udc/parttopart" xmlns:st="" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns="http://www.w3.org/TR/REC-html40"
xmlns:ns1="http://schemas.microsoft.com/sharepoint/soap/workflow/"
xmlns:ns2="http://schemas.microsoft.com/office/2006/digsig-setup"
xmlns:ns3="http://schemas.microsoft.com/office/2006/digsig"
xmlns:ns4="http://schemas.openxmlformats.org/package/2006/digital-signature"
xmlns:ns5="http://schemas.openxmlformats.org/markup-compatibility/2006"
xmlns:ns0="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:ns6="http://schemas.openxmlformats.org/package/2006/relationships"
xmlns:ns7="http://microsoft.com/sharepoint/webpartpages"
xmlns:ns8="http://schemas.microsoft.com/exchange/services/2006/types"
xmlns:ns9="http://schemas.microsoft.com/exchange/services/2006/messages"
xmlns:ns10="http://schemas.microsoft.com/sharepoint/soap/SlideLibrary/"
xmlns:ns11="http://microsoft.com/webservices/SharePointPortalServer/PublishedLinksService"
xmlns:ns12="urn:schemas-microsoft-com:">
<head>
<meta http-equiv=Content-Type content="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 11 (filtered medium)">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><o:SmartTagType
namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
name="place"/>
<!--[if !mso]>
<style>
st1\:*{behavior:url(#default#ieooui) }
</style>
<![endif]-->
<style>
<!--a:link
{mso-style-priority:99;}
span.MSOHYPERLINK
{mso-style-priority:99;}
a:visited
{mso-style-priority:99;}
span.MSOHYPERLINKFOLLOWED
{mso-style-priority:99;}
p
{mso-style-priority:99;}
p.MSOACETATE
{mso-style-priority:99;}
li.MSOACETATE
{mso-style-priority:99;}
div.MSOACETATE
{mso-style-priority:99;}
span.TEXTODEBALOCHAR
{mso-style-priority:99;}
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman";}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{color:purple;
text-decoration:underline;}
p
{mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:Tahoma;}
span.TextodebaloChar
{font-family:Tahoma;}
span.EmailStyle21
{mso-style-type:personal;
font-family:Calibri;
color:windowtext;}
p.Textodebalo, li.Textodebalo, div.Textodebalo
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman";}
span.EmailStyle23
{mso-style-type:personal-reply;
font-family:Arial;
color:navy;}
@page Section1
{size:8.5in 11.0in;
margin:70.85pt 85.05pt 70.85pt 85.05pt;}
div.Section1
{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=EN-US link=blue vlink=purple style='word-wrap: break-word;
-webkit-nbsp-mode: space;-webkit-line-break: after-white-space'>
<div class=Section1>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'>Christine Petersen published an article
about transplacental transmission of L infantum in the <st1:country-region
w:st="on"><st1:place w:st="on">USA</st1:place></st1:country-region> canine
leishmaniasis. I just wonder about the implication of this finding in
considering vaccination against the disease transmitted this way ?<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'><o:p> </o:p></span></font></p>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'>KP<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'><o:p> </o:p></span></font></p>
<div>
<div class=MsoNormal align=center style='text-align:center'><font size=3
face="Times New Roman"><span style='font-size:12.0pt'>
<hr size=2 width="100%" align=center tabindex=-1>
</span></font></div>
<p class=MsoNormal><b><font size=2 face=Tahoma><span style='font-size:10.0pt;
font-family:Tahoma;font-weight:bold'>From:</span></font></b><font size=2
face=Tahoma><span style='font-size:10.0pt;font-family:Tahoma'> leish-l-bounces@lineu.icb.usp.br
[mailto:leish-l-bounces@lineu.icb.usp.br] <b><span style='font-weight:bold'>On
Behalf Of </span></b>TECSA - Luiz Ristow<br>
<b><span style='font-weight:bold'>Sent:</span></b> Wednesday, September 28,
2011 9:08 AM<br>
<b><span style='font-weight:bold'>To:</span></b> 'John David'<br>
<b><span style='font-weight:bold'>Cc:</span></b> leish-l@lineu.icb.usp.br<br>
<b><span style='font-weight:bold'>Subject:</span></b> [Leish-l] RES: testing
vaccinated dogs for immunopotentiation</span></font><o:p></o:p></p>
</div>
<p class=MsoNormal><font size=3 face="Times New Roman"><span style='font-size:
12.0pt'><o:p> </o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>Hi !<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'><o:p> </o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>There are these papers about<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>These need a very critical reading to discuss<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>This discussion with all about the matter and these
papers is very welcome! (at least for me!)<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>Regards for all<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'>Luiz Ristow<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'><o:p> </o:p></span></font></p>
<div>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'><img width=383 height=152 id="Imagem_x005f_x0020_1"
src="cid:image001.gif@01CC7DC6.287059B0" alt="assinatura de email dr luiz"><o:p></o:p></span></font></p>
</div>
<p class=MsoNormal><font size=2 face=Calibri><span lang=PT-BR style='font-size:
11.0pt;font-family:Calibri'><o:p> </o:p></span></font></p>
<div>
<div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'>
<p class=MsoNormal><b><font size=2 face=Tahoma><span lang=PT-BR
style='font-size:10.0pt;font-family:Tahoma;font-weight:bold'>De:</span></font></b><font
size=2 face=Tahoma><span lang=PT-BR style='font-size:10.0pt;font-family:Tahoma'>
leish-l-bounces@lineu.icb.usp.br [mailto:leish-l-bounces@lineu.icb.usp.br] <b><span
style='font-weight:bold'>Em nome de </span></b>John David<br>
<b><span style='font-weight:bold'>Enviada em:</span></b> segunda-feira, 26 de
setembro de 2011 18:44<br>
<b><span style='font-weight:bold'>Para:</span></b> Dr GR Rajasekariah<br>
<b><span style='font-weight:bold'>Cc:</span></b> leish-l@lineu.icb.usp.br;
Carlos Gouvea; hubert mazure; smithyman@cellabs.com.au<br>
<b><span style='font-weight:bold'>Assunto:</span></b> Re: [Leish-l] testing
vaccinated dogs for immunopotentiation<o:p></o:p></span></font></p>
</div>
</div>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>I think that for any vaccine developed to protect dogs against VL,
but which is also meant to prevent transmission of VL to humans, the developers
should show that after the vaccinated dog has been challenged with Leishmania,
it does not transmit Leishmania to sand flies.</span></font><span lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face="Times New Roman"><span lang=PT-BR style='font-size:12.0pt'>John R
David, M.D.<o:p></o:p></span></font></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Richard Pearson Strong Professor Emeritus</span></font><span
lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Department of Immunology and Infectious Diseases</span></font><span
lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Harvard School of Public Health</span></font><span lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Professor of Medicine, Harvard Medical School</span></font><span
lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>300 W. 23rd Street, Apt. 13K</span></font><span lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>New York, NY, 10011</span></font><span lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Tel: 212 414 8646</span></font><span lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'>Email: <a href="mailto:jdavid@hsph.harvard.edu">jdavid@hsph.harvard.edu</a></span></font><span
lang=PT-BR><o:p></o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><font
size=3 face=Helvetica><span lang=PT-BR style='font-size:12.0pt;font-family:
Helvetica'> </span></font><span lang=PT-BR><o:p></o:p></span></p>
<div>
<div>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</div>
<div>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>On Sep 19, 2011, at 12:04 AM, Dr GR Rajasekariah
wrote:<o:p></o:p></span></font></p>
</div>
<p class=MsoNormal style='margin-bottom:12.0pt'><font size=3
face="Times New Roman"><span lang=PT-BR style='font-size:12.0pt'><o:p> </o:p></span></font></p>
<div>
<p class=MsoNormal style='margin-bottom:12.0pt'><font size=3
face="Times New Roman"><span lang=PT-BR style='font-size:12.0pt'>Hello
EveryOne,<br>
I am responding to the topic on European VL Dog vaccine.<br>
It is a great challenge in devising a protective vaccine against visceral
leishmaniasis in dogs. This point equally applies the same challenge for human
situation.<br>
Because Th-2 response is so dominant during VL infection, modulating Th-2 into
Th-1 response is a big challenge to immunologists.<br>
<br>
Key points lies in the presentation of appropriate antigen in appropriate dose
to stimulate the Th-1 dependent protective immune response.<br>
I understand several vaccines are in the market and real efficacy of these
vaccines will come out once introduced to field conditions.<br>
<br>
I just wanted to inform you that we have a suitable antibody kit for
testing the immunopotentiation in dogs following vaccination of dogs.<br>
Our assay is based on the released promastigote antigens.<br>
It is a highly sensitive assay.<br>
Currently we supply reagents for determination of total IgG antibodies in
serum.<br>
If any particular group is interested then we are able to provide appropriate
reagent for detection of specific IgG2 and other isotype specific antibody
detection.<br>
Because our antibody detection ELISA is based on the exo-antigens such an ELISA
would be of exceptional type for measuring antibody response in vaccinated
animals.<br>
Highly suitable for diagnosing dogs responded to vaccines.<br>
<br>
Recently I came to know that some of commercial kits were found to be not
useful for detecting seroconversion in dogs vaccinated with FML vaccine
(Leish-Immune) in Brazil.<br>
Because we use released antigens in our kit, any such problems will overcome if
they use Canine Leish IgG CELISA (Manufacturer Cellabs Pty Ltd Brookvale NSW
Australia email <a href="mailto:sales@cellabs.com.au">sales@cellabs.com.au</a>).<br>
If any one is interested to know more about our antibody detection ELISA based
on exo-antigens please contact us.<br>
<br>
This is for your kind information.<br>
<br>
Dr GR Rajasekariah<br>
Sydney<br>
Australia<br>
<a href="mailto:raj@cellabs.com.au">raj@cellabs.com.au</a><br>
<br>
<br>
<br>
<br>
<br>
<br>
----- Original Message ----- From: <leish-l-request@lineu.icb.usp.br><br>
To: <leish-l@lineu.icb.usp.br><br>
Sent: Wednesday, August 10, 2011 5:18 PM<br>
Subject: Leish-l Digest, Vol 44, Issue 3<br>
<br>
<br>
<o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Send Leish-l mailing list submissions to<o:p></o:p></span></font></p>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>leish-l@lineu.icb.usp.br<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>To subscribe or unsubscribe via the World Wide Web,
visit<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>or, via email, send a message with subject or body
'help' to<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>leish-l-request@lineu.icb.usp.br<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>You can reach the person managing the list at<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>leish-l-owner@lineu.icb.usp.br<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>When replying, please edit your Subject line so it is
more specific<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>than "Re: Contents of Leish-l digest..."<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Today's Topics:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 1. European VL Dog Vaccine - CaniLeish?:
(jeffrey shaw)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 2. Re: FW: Leishmaniasis Pathology Network
(Moazzem Hossain)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 3. Re: FW: Leishmaniasis Pathology Network
(Moazzem Hossain)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>----------------------------------------------------------------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message: 1<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Date: Tue, 9 Aug 2011 15:18:44 +0000<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>From: jeffrey shaw <jayusp@hotmail.com><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Subject: [Leish-l] European VL Dog Vaccine -
CaniLeish?:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>To: Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message-ID:
<COL101-W1CDD4171D44B715B795E9CB200@phx.gbl><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Content-Type: text/plain;
charset="windows-1252"<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>CaniLeish?:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> The European Commission granted a
marketing authorisation valid throughout the European Union, for CaniLeish to
Virbac S.A. on 14/03/2011.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> This vaccine, CaniLeish?, will initially be
launched in Portugal at the end of the first half of 2011. This will be
followed rapidly by launches in other countries in the endemic area: Spain,
France, Greece and Italy (not in chronological order). This roll-out takes
account of the geographical prevalence of the disease and the time required to
build vaccine production up to full capacity. The launch in Northern European
countries from where there is a flow of summer visitors to the endemic area
will be part of a second phase.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> The basis of this vaccine are excreted
proteins plus a saponin adjuvant purified from Quil-A. Its efficacy was
determined in a 2 year open field trial.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> The vaccine is given to dogs as three
injections, three weeks apart, under the skin. The first injection can be given
from six months of age, the second injection is given three weeks later and the
third three weeks from the second one. Afterward a single ?booster? should be
given every year to maintain protection.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>-------------- next part --------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>An HTML attachment was scrubbed...<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>URL:
<http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110809/f2404f5e/attachment-0001.htm><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>------------------------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message: 2<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Date: Wed, 10 Aug 2011 13:07:17 +0600<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>From: Moazzem Hossain <directordcbd@gmail.com><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology
Network<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>To: jeffrey shaw <jayusp@hotmail.com>,
"Prof. Paul Kaye"<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><paul.kaye@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Cc: "Prof. Dr. Moazzem Hossain"
<profdrmoazzemhossain@gmail.com>,<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message-ID:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><CAE-TCmS=i=WaT8cAeOXUJmot=KPvMQSLKar6CTfuUBK9M9tsUw@mail.gmail.com><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Content-Type: text/plain; charset=windows-1252<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>10 Aug 2011<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Dear Professor Paul Kaye,<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Thank you for your email. Please find attached our
supportive letter<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>of interest for Leishmaniasis Pathology Network.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Looking forward for your kind response.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Best regards.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>-- <o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>*Prof. Dr. Moazzem Hossain *<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Ex - Director Disease Control<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Ministry of Health & Family Welfare<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Government of Bangladesh<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>*Mailing address*:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Founder Chairman and Project Director<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Institute of Allergy & Clinical Immunology of
Bangladesh (IACIB)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Dhaka -1205, Bangladesh.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Phone:880-2-8115646 (O )<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 880-1715038551(Mobile)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: directordcbd@gmail.com<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>On 8/9/11, jeffrey shaw <jayusp@hotmail.com>
wrote:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>From: paul.kaye@york.ac.uk<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Subject: Leishmaniasis Pathology Network<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Dear all,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Invitation to participate in a
global pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network for<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> research and training in
leishmaniasis (LeishPathNet)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> You may recall the Dormy House
meeting in 2008<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> and some of<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the plans we put
forward? Over<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the past<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> couple years, I have
also spoken more to a few of you about one<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> idea that was<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> formulated at Dormy,
namely of setting up a digital pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network. I have<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> also had numerous
discussions with the major equipment<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> manufacturers to see if<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> any of them would be
supportive of helping us to develop such an<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initiative. There
have<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> been two major<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> develoments recently.
First,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Carl Zeiss<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> is willing to work with
us to set up an integrated global digital<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network (providing a
significant financial and technical<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> contribution) and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> second, the Wellcome
Trust is willing to review a pre-proposal to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> fund the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initiative through their
new Biomedical Resources Grant scheme<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>(http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> .<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I have attached an outline of the
project that<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I had sent to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the Trust for their
initial views, which I think is reasonably<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> self-explanatory.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> They appeared very<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> enthusiastic! The
main<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> question now is whether
enough of<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> you are still
supportive? [ I will also be sending this email to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> others, but please feel
free to circulate ]<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I think the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> project will
be<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> challenging,
but success could have a real impact on the way we<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> conduct<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> business.
It should serve not only as a vehicle to enhance<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> research in<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> leishmaniasis,
but the model would be equally applicable across<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> a broad
range<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> of diseases
and global challenges (with leishmaniasis setting<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the pace).<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If we wish to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> proceed, the
requirements<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> are that we
submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> This pre-proposal
is short (4 sections of 350 words) and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> requires<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letters of
support from the community.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If you are<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> supportive
of the idea that<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> we try to
take this forward (and there is plenty of scope for<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> later
iteration<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> of the
detail), I would be grateful if you could please provide<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> me with a<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letter of
support by September<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 12th<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 2011,
indicating whether you would like to be a network<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> partner if
the bid<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> is
successful. You could<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> also be<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> supportive
but not wish to become directly involved at this<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> stage, and
such<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letters are
equally valuable. Your letter might also stress the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> added value<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> that the
network could provide, its importance for research and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> training
and/or<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> for
progressing the translational agenda.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> It would
also be an opportunity to indicate whether your<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> group (or<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> institute,
if multiple groups) would be interested in bidding to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> be one of
the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initial
?designated laboratories?.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If there is<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> sufficient
support to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> proceed and
if subsequently the pre-proposal is successful (we<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> will know on
22nd<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Nov), then I
will need a few volunteers to help finalise the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> full
proposal,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> which will
be due on Jan 26th 2012.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> A funding
decision will be made on May 26th<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 2012.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Best wishes<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> and of
course I am happy to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> discuss any
points further (though I will be out of the UK from<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Aug 10 ?Sept<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 12)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Paul<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> --<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Director, Centre for Immunology and Infection<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Department of Biology and Hull York Medical School<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>University of York<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Wentworth Way<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>York YO10 5YW<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>United Kingdom<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Tel: +44 (0)1904 328840<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Fax: +44 (0)1904 328844<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: paul.kaye@york.ac.uk
<mailto:paul.kaye@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Tel: 01904 328845<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: liz.greensted@york.ac.uk <mailto:liz.greensted@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre Email: cii@york.ac.uk
<mailto:cii@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre website: http://www.york.ac.uk/cii<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Times Higher Education University of the Year 2010<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email disclaimer:
http://www.york.ac.uk/docs/disclaimer/email.htm<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>------------------------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message: 3<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Date: Wed, 10 Aug 2011 13:06:47 +0600<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>From: Moazzem Hossain <directordcbd@gmail.com><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology
Network<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>To: jeffrey shaw <jayusp@hotmail.com>,
"Prof. Paul Kaye"<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><paul.kaye@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Cc: "Prof. Dr. Moazzem Hossain"
<profdrmoazzemhossain@gmail.com>,<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Message-ID:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><CAE-TCmQNUkZdNE5w+Z20bjLC-=vvV9BCP6OLOm9f6RV-BfpXvA@mail.gmail.com><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Content-Type: text/plain;
charset="windows-1252"<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>10 Aug 2011<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Dear Professor Paul Kaye,<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Thank you for your email. Please find attached our
supportive letter<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>of interest for Leishmaniasis Pathology Network.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Looking forward for your kind response.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Best regards.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>-- <o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>*Prof. Dr. Moazzem Hossain *<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Ex - Director Disease Control<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Ministry of Health & Family Welfare<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Government of Bangladesh<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>*Mailing address*:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Founder Chairman and Project Director<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Institute of Allergy & Clinical Immunology of
Bangladesh (IACIB)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Dhaka -1205, Bangladesh.<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Phone:880-2-8115646 (O )<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 880-1715038551(Mobile)<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: directordcbd@gmail.com<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>On 8/9/11, jeffrey shaw <jayusp@hotmail.com>
wrote:<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>From: paul.kaye@york.ac.uk<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Subject: Leishmaniasis Pathology Network<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Dear all,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Invitation to participate in a
global pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network for<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> research and training in
leishmaniasis (LeishPathNet)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> You may recall the Dormy House
meeting in 2008<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> and some of<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the plans we put
forward? Over<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the past<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> couple years, I have
also spoken more to a few of you about one<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> idea that was<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> formulated at Dormy,
namely of setting up a digital pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network. I have<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> also had numerous discussions
with the major equipment<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> manufacturers to see if<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> any of them would be
supportive of helping us to develop such an<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initiative. There
have<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> been two major<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> develoments recently.
First,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Carl Zeiss<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> is willing to work with
us to set up an integrated global digital<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> pathology<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> network (providing a
significant financial and technical<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> contribution) and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> second, the Wellcome
Trust is willing to review a pre-proposal to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> fund the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initiative through their
new Biomedical Resources Grant scheme<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>(http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> .<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I have attached an outline of the
project that<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I had sent to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the Trust for their
initial views, which I think is reasonably<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> self-explanatory.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> They appeared very<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> enthusiastic! The
main<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> question now is whether
enough of<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> you are still
supportive? [ I will also be sending this email to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> others, but please feel
free to circulate ]<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> I think the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> project will
be<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> challenging,
but success could have a real impact on the way we<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> conduct<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> business.
It should serve not only as a vehicle to enhance<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> research in<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> leishmaniasis,
but the model would be equally applicable across<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> a broad
range<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> of diseases
and global challenges (with leishmaniasis setting<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> the pace).<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If we wish to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> proceed, the
requirements<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> are that we
submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> This
pre-proposal is short (4 sections of 350 words) and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> requires<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letters of
support from the community.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If you are<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> supportive
of the idea that<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> we try to
take this forward (and there is plenty of scope for<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> later
iteration<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> of the
detail), I would be grateful if you could please provide<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> me with a<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letter of
support by September<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 12th<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 2011,
indicating whether you would like to be a network<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> partner if
the bid<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> is
successful. You could<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> also be<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> supportive
but not wish to become directly involved at this<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> stage, and
such<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> letters are
equally valuable. Your letter might also stress the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> added value<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> that the
network could provide, its importance for research and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> training
and/or<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> for
progressing the translational agenda.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> It would
also be an opportunity to indicate whether your<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> group (or<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> institute,
if multiple groups) would be interested in bidding to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> be one of
the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> initial
?designated laboratories?.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> If there is<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> sufficient
support to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> proceed and
if subsequently the pre-proposal is successful (we<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> will know on
22nd<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Nov), then I
will need a few volunteers to help finalise the<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> full
proposal,<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> which will
be due on Jan 26th 2012.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> A funding
decision will be made on May 26th<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 2012.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Best wishes<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> and of
course I am happy to<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> discuss any
points further (though I will be out of the UK from<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Aug 10 ?Sept<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> 12)<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> Paul<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'> --<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Director, Centre for Immunology and Infection<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Department of Biology and Hull York Medical School<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>University of York<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Wentworth Way<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>York YO10 5YW<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>United Kingdom<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Tel: +44 (0)1904 328840<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Fax: +44 (0)1904 328844<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: paul.kaye@york.ac.uk <mailto:paul.kaye@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Tel: 01904 328845<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email: liz.greensted@york.ac.uk
<mailto:liz.greensted@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre Email: cii@york.ac.uk
<mailto:cii@york.ac.uk><o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Centre website: http://www.york.ac.uk/cii<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Times Higher Education University of the Year 2010<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Email disclaimer:
http://www.york.ac.uk/docs/disclaimer/email.htm<o:p></o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>-------------- next part --------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>A non-text attachment was scrubbed...<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Name: Letter Leish UK.doc<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Type: application/msword<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Size: 46080 bytes<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Desc: not available<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>URL:
<http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110810/73f2ae6a/attachment.doc><o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>------------------------------<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>_______________________________________________<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Leish-l mailing list<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>Leish-l@lineu.icb.usp.br<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>End of Leish-l Digest, Vol 44, Issue 3<o:p></o:p></span></font></p>
</blockquote>
<blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'>************************************** <o:p></o:p></span></font></p>
</blockquote>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><br>
<br>
<br>
<br>
<br>
=======<br>
Email scanned by PC Tools - No viruses or spyware found.<br>
(Email Guard: 7.0.0.26, Virus/Spyware Database: 6.18330)<br>
http://www.pctools.com/<br>
=======<br>
_______________________________________________<br>
Leish-l mailing list<br>
Leish-l@lineu.icb.usp.br<br>
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></span></font></p>
</div>
</div>
<p class=MsoNormal><font size=3 face="Times New Roman"><span lang=PT-BR
style='font-size:12.0pt'><o:p> </o:p></span></font></p>
<div>
<div>
<div>
<p style='margin:0in;margin-bottom:.0001pt'><font size=2 face="Times New Roman"><span
lang=PT-BR style='font-size:10.5pt'><o:p> </o:p></span></font></p>
</div>
</div>
</div>
</div>
</body>
</html>